It faces more than 1,800 lawsuits consolidated in federal court in Pennsylvania and new claims emerging weekly, according to ...

Novo Nordisk has implemented a global hiring freeze covering job roles that are not critical for its business, Reuters writes ...

THE price of Mounjaro is set to soar next month – leaving those using the jabs – and those desperate to slim down concerned at how they will afford the ‘miracle’ injections. Now, many ...

Ready Health, a leading private medical practice in Standish, Wigan, has announced a remarkable milestone: patients using their safe and effective weight loss injection services have collectively lost ...

The weight loss drug, which was previously also used to treat diabetes, may be having an unexpected impact on a rather sensitive body part ...

Non-arteritic anterior ischaemic optic neuropathy, or NAION, is a rare but devastating eye condition that occurs when blood ...

The manufacturer of Ozempic (and other Semaglutide brands) faces over $2 billion in lawsuits filed by over 1,800 patients claiming blindness, stomach paralysis, and more.

GoodRx reports that insurance formularies are shrinking, leading to fewer covered medications and increased restrictions on ...

Employers surveyed by the Business Group on Health are bracing for the largest annual increase in healthcare costs in more ...

Viking Therapeutics, Inc.'s VK2735 trial results disappointed, yet long-term potential in the obesity market makes the stock ...

Although the FDA has since removed these drugs from its shortage list, stakeholders say compounded drugs continue to be sold.

Diabetes drug Ozempic will cost half-price for US patients paying cash - The drug is available as a weight-loss medication ...